12 Cholinesterase Inhibitors Flashcards
Purpose
Reverse non-depolarizing muscle blockade
Maximize nicotinic transmission with minimum muscarinic side effects
Rx Examples
Neostigmine, edrophonium, pyridostigmine, physostigmine
Where is ACh active
- Neurotransmitter for parasympathetic nervous system: ganglions and effector cells
- Parts of sympathetic: sympathetic ganglia, adrenal medulla, sweat glands
- Somatic nerves
- Some neurons of CNS
2 subtypes of cholinergic receptors & locations
- Nicotinic - somatic motor neurons; blocked by muscle relaxants and/or anticholinergics
- Muscarinic - CNS & autonomic locations (specifically: bronchial smooth muscle, salivary glands, SA note); blocked by anticholinergic (e.g atropine)
Cholinesterase inhibitors: Mechanism of Action
Stop degradation of ACh
Indirectly increase amount of ACh available to compete with nondepolarizing agent
In excessive doses, paradoxically potentiate nondepolarizing neuromuscular blockade
Muscarinic Side Effects
Muscarinic receptors for autonomic & CNS.
Increase in ACh caused by cholinesterase inhibitors, by activating muscarinic receptors, causes:
CV - bradycardia
Pulmonary - bronchospasm, increased respiratory tract secretions
Cerebral - physostigmine crosses BBB
GI - increase peristaltic activity, PONV, fecal incontinence
Minimized by prior/concomitant admin of anticholinergic
Cholinesterase Inhibitors Clearance
Hepatic metabolism (25-50%) and renal excretion (50-75%)
Tetany and cholinesterase inhibitors
If no tetanic peripheral nerve stimulation, block too intense for cholinesterase inhibitor to reverse block
Palpable post-tetanic twitch appears ~10-40 min prior to first twitch of TOF
Higher frequency of stimulation, great specificifty of test: 100 Hz tetany > 50 Hz tetany or TOF > single twitch height
Neostigmine
Lipid insoluble, doesn’t pass through BBB
0.04-0.08 mg/kg (up to 5 mg in adults)
Effects in 5 minutes, last ~ 1 hr
Admin with glycopyrrolate: 0.2mg / 1 mg neostigmine
Neostigmine crosses placenta, theoretically causing fetal bradycardia
Pyridostigmine
20% as potent as neostigmine
0.1-0.25 mg/kg
Slower onset (10-15 min), longer duration (>2 hr)
Doesn’t cross BBB
Glycopyrrolate: 0.05 mg / 1 mg pyridostigmine
Edrophonium
10% as potent as neostigmine
0.5-1 mg/kg
Rapid onset (1-2 min), shortest duration
Atropine: 0.014 mg / 1 mg edrophonium
Would need to give glycol several minutes before to avoid bradycardia
Physostigmine
Lipid soluble - crosses BBB - less useful to reverse neuromuscular blockade - used for treatment of central anticholinergic toxicity
0.01-0.03 mg/kg
Sugammadex
Hydrophobic interactions trap steroid (Roc, Vec, Pancuronium) in cyclodextrin cavity
Tight 1:1 complex
Terminates neuromuscular blockade
Unchanged renal excretion